Related Experiment Video
Updated: Aug 30, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Antiretroviral use in Ouagadougou, Burkina Faso
Vinh-Kim Nguyen1, Troy Grennan, Karine Peschard
1Department of Social Studies of Medicine, McGill University, Montréal,Québec, Canada. vinh-kim.nguyen@mcgill.ca
Abstract:
Burkina Faso has the second highest seroprevalence rate for HIV in West Africa, estimated at 6.5% of the population. Although it is one of the poorest countries in the world, antiretrovirals have been used on an extremely limited basis in Burkina Faso since at least the early 1990s. In this article we will review the evolution of antiretroviral availability in this country, describe the mechanisms by which drugs are being accessed, and review our experience with expanding antiretroviral access through drug donations in community-based settings. Finally, we will discuss some of the implications for future attempts to expand access to treatment for people living with HIV in Africa.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Antiviral Nucleoside Inhibitors
Subviral Agents
Antiprotozoal Agents
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

